Cutaneous manifestations in neurofibromatosis type 1

被引:36
|
作者
Miraglia, E. [1 ]
Moliterni, E. [1 ]
Lacovino, C. [1 ]
Roberti, V [1 ]
Laghi, A. [1 ]
Moramarco, A. [2 ]
Giustini, S. [1 ]
机构
[1] Sapienza Univ Rome, Dermatol Clin, Rome, Italy
[2] Sapienza Univ Rome, Dept Sense Organs, Rome, Italy
来源
CLINICA TERAPEUTICA | 2020年 / 171卷 / 05期
关键词
Cafe-au-lait macules; cutaneous manifestations; freckling; neurofibromatosis type 1; neurofibroma; neurofibromin; RETINAL MICROVASCULAR ABNORMALITIES; AU LAIT MACULES; POLIOSIS CIRCUMSCRIPTA; BECKERS NEVUS; IN-VIVO; NF1; PATIENT; ASSOCIATION; EXPERIENCE; SPOTS;
D O I
10.7417/CT.2020.2242
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To better understand the real prevalence of cutaneous manifestations, in Neurofibromatosis type 1. Materials and Methods. We reviewed all clinical charts of 1102 NF1 patients followed by February 1983 to February 2020 at the "Sapienza" University of Rome, Italy. NF1 patients are seen usually every year by a dermatologist. Results. Cafe-au-lait macules were shown in 1063 patients (96.5%), axillary and inguinal freckling in 991 (90%) and neurofibromas in 861 (78.1%). Other skin manifestations included: lipoma (6.2%), nevus anemicus (3.9%), psoriasis (3.4%), spilus nevus (3.2%), juvenile xanthogranuloma ( 3.2%), vitiligo (2.3%), Becker's nevus (1.9%), melanoma (0.7%) and poliosis (0.5%). Conclusions. Neurofibromatosis type 1 is a multisystem disorder primarily involving the skin and nervous system. The clinical manifestations are extremely variable even within a family. This study was performed to delineate the prevalence of cutaneous manifestations in NF1.
引用
收藏
页码:E371 / E377
页数:7
相关论文
共 50 条
  • [21] Cutaneous squamous cell carcinoma in a patient with neurofibromatosis type 1: A case report
    Ishida, Mitsuaki
    Okabe, Hidetoshi
    ONCOLOGY LETTERS, 2013, 6 (04) : 878 - 880
  • [22] Recent advances in neurofibromatosis type 1
    Arun, D
    Gutmann, DH
    CURRENT OPINION IN NEUROLOGY, 2004, 17 (02) : 101 - 105
  • [23] Neurofibromatosis type 1
    Anders, Rebecca
    Hirsch, Franz Wolfgang
    Roth, Christian
    PAEDIATRIE UND PAEDOLOGIE, 2024, 59 (02): : 95 - 103
  • [24] Cutaneous Plexiform Schwannomas in a Patient with Neurofibromatosis Type 2
    Ko, Joo Yeon
    Kim, Ji Eun
    Kim, Young Hoon
    Ro, Young Suck
    ANNALS OF DERMATOLOGY, 2009, 21 (04) : 402 - 405
  • [25] Aberrant cutaneous expression of the angiogenic factor midkine is associated with neurofibromatosis type-1
    Mashour, GA
    Wang, HL
    Cabal-Manzano, R
    Wellstein, A
    Martuza, RL
    Kurtz, A
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 113 (03) : 398 - 402
  • [26] Mosaic Neurofibromatosis Type 1 With Multiple Cutaneous Diffuse and Plexiform Neurofibromas of the Lower Leg
    Friedrich, Reinhard E.
    Hagel, Christian
    Kohlrusch, Felix K.
    Schanze, Ina
    Wieland, Ilse
    Zenker, Martin
    ANTICANCER RESEARCH, 2020, 40 (06) : 3423 - 3427
  • [27] Minimal intervention for neurofibromatosis type I manifestations: A case report
    Saad, Reem Hassan
    Medra, Ahmed Mohamed
    Saadallah, Omar Alaaeldin
    El Mallah, Mostafa Mohamed
    INTERNATIONAL JOURNAL OF SURGERY CASE REPORTS, 2023, 110
  • [28] 2016 Children's Tumor Foundation conference on neurofibromatosis type 1, neurofibromatosis type 2, and schwannomatosis
    Fisher, Michael J.
    Belzberg, Allan J.
    de Blank, Peter
    De Raedt, Thomas
    Elefteriou, Florent
    Ferner, Rosalie E.
    Giovannini, Marco
    Harris, Gordon J.
    Kalamarides, Michel
    Karajannis, Matthias A.
    Kim, AeRang
    Lazaro, Conxi
    Le, Lu Q.
    Li, Wei
    Listernick, Robert
    Martin, Staci
    Morrison, Helen
    Pasmant, Eric
    Ratner, Nancy
    Schorry, Elisabeth
    Ullrich, Nicole J.
    Viskochil, David
    Weiss, Brian
    Widemann, Brigitte C.
    Zhu, Yuan
    Bakker, Annette
    Serra, Eduard
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2018, 176 (05) : 1258 - 1269
  • [29] Dissecting Clinical Heterogeneity in Neurofibromatosis Type 1
    Monroe, Courtney L.
    Dahiya, Sonika
    Gutmann, David H.
    ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 12, 2017, 12 : 53 - 74
  • [30] A Review of Spinal Lesions in Neurofibromatosis Type 1 in a Large Neurofibromatosis Type 1 Center
    Sial, Moska
    George, K. Joshi
    WORLD NEUROSURGERY, 2023, 169 : E157 - E163